Boston Partners Buys 28,097 Shares of Constellium SE (NYSE:CSTM)

Boston Partners grew its position in shares of Constellium SE (NYSE:CSTMFree Report) by 27.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 131,272 shares of the industrial products company’s stock after purchasing an additional 28,097 shares during the quarter. Boston Partners owned about 0.09% of Constellium worth $1,348,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CSTM. Mountaineer Partners Management LLC boosted its position in shares of Constellium by 1,683.0% during the 3rd quarter. Mountaineer Partners Management LLC now owns 8,928,919 shares of the industrial products company’s stock valued at $145,184,000 after purchasing an additional 8,428,150 shares in the last quarter. Thrivent Financial for Lutherans boosted its holdings in shares of Constellium by 242.7% during the 4th quarter. Thrivent Financial for Lutherans now owns 1,522,400 shares of the industrial products company’s stock worth $15,636,000 after buying an additional 1,078,196 shares in the last quarter. Empowered Funds LLC acquired a new stake in shares of Constellium during the 4th quarter worth approximately $5,856,000. FMR LLC increased its stake in shares of Constellium by 3.4% in the 3rd quarter. FMR LLC now owns 14,681,988 shares of the industrial products company’s stock valued at $238,729,000 after acquiring an additional 484,011 shares in the last quarter. Finally, Kailix Advisors LLC lifted its position in shares of Constellium by 25.6% during the 4th quarter. Kailix Advisors LLC now owns 2,085,187 shares of the industrial products company’s stock valued at $21,415,000 after acquiring an additional 424,779 shares during the period. Institutional investors and hedge funds own 92.59% of the company’s stock.

Constellium Price Performance

Shares of NYSE:CSTM opened at $11.35 on Friday. The stock’s 50 day moving average is $10.60 and its 200-day moving average is $12.13. Constellium SE has a twelve month low of $9.04 and a twelve month high of $23.20. The company has a quick ratio of 0.52, a current ratio of 1.28 and a debt-to-equity ratio of 1.93. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of 35.46 and a beta of 1.64.

Constellium (NYSE:CSTMGet Free Report) last issued its quarterly earnings data on Thursday, February 20th. The industrial products company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.47). Constellium had a net margin of 0.67% and a return on equity of 4.83%. The business had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.69 billion. Sell-side analysts forecast that Constellium SE will post 1.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft raised shares of Constellium from a “hold” rating to a “buy” rating and set a $15.00 price target for the company in a research note on Tuesday, February 25th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Check Out Our Latest Stock Report on CSTM

About Constellium

(Free Report)

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.

Recommended Stories

Institutional Ownership by Quarter for Constellium (NYSE:CSTM)

Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.